Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Clinical Trials at the Cancer Institute of New Jersey – Hamilton Currently recruiting participants (updated as of September 17, 2015) Breast Cancer SWOG S1007 SWOG S1207 NSABP B-55 ECOG E-2112 Lymphedema Registry by Stanford University Medical Center Gynecologic CINJ 130909 Colon CALGB C80702 A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with HighRisk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer A Randomised, Double-Blind, Parallel Group, Placebo-Controlled Multi-Centre Phase III Study to Assess the Efficacy and Safety of Olaparib Versus Placebo as Adjuvant Treatment in Patients with Germline BRCA1/2 Mutations and High Risk HER2 Negative Primary Breast Cancer Who Have Completed Definitive Local Treatment and Neoadjuvant or Adjuvant Chemotherapy A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Men and Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer A registry to study breast cancer-related lymphedema. By collecting your health information, we hope to learn whether early diagnosis will help to prevent lymphedema or, if it occurs, to reduce the severity. Psychological Interventions for Gynecologic Cancer A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer Chronic Lymphocytic Leukemia (CLL) A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus A041202 Rituximab Versus Ibrutinib Alone in Untreated Older Patients (>= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL) Cancer Patients and Care givers The Cancer A survey for patients and care givers to share their story, that can help bring Experience Registry knowledge and insights about their social and emotional needs and provide them Trial with information on the development of new programs, research and policy. Adult Patients undergoing a Nipple Sparing Mastectomy ASBrS Nipple The American Society of Breast Surgeons would like to use your health Sparing Mastectomy information in a Nipple Sparing Mastectomy Registry. By placing the health Registry information of many patients such as you into a research registry, researchers will be able to increase their knowledge about breast cancer and answer questions about breast cancer and its treatment. For more information, please contact the Research Office at 609-631-6946